We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cbl-b regulates the CD28 dependence of T-cell activation.
- Authors
Chiang, Y J; Kole, H K; Brown, K; Naramura, M; Fukuhara, S; Hu, R J; Jang, I K; Gutkind, J S; Shevach, E; Gu, H
- Abstract
Whereas co-stimulation of the T-cell antigen receptor (TCR) and CD28 triggers T-cell activation, stimulation of the TCR alone may result in an anergic state or T-cell deletion, both possible mechanisms of tolerance induction. Here we show that T cells that are deficient in the adaptor molecule Cbl-b (ref. 3) do not require CD28 engagement for interleukin-2 production, and that the Cbl-b-null mutation (Cbl-b(-/-)) fully restores T-cell-dependent antibody responses in CD28-/- mice. The main TCR signalling pathways, such as tyrosine kinases Zap-70 and Lck, Ras/mitogen-activated kinases, phospholipase Cgamma-1 and Ca2+ mobilization, were not affected in Cbl-b(-/-) T cells. In contrast, the activation of Vav, a guanine nucleotide exchange factor for Rac1/Rho/CDC42, was significantly enhanced. Our findings indicate that Cbl-b may influence the CD28 dependence of T-cell activation by selectively suppressing TCR-mediated Vav activation. Mice deficient in Cbl-b are highly susceptible to experimental autoimmune encephalomyelitis, suggesting that the dysregulation of signalling pathways modulated by Cbl-b may also contribute to human autoimmune diseases such as multiple sclerosis.
- Publication
Nature, 2000, Vol 403, Issue 6766, p216
- ISSN
0028-0836
- Publication type
Journal Article
- DOI
10.1038/35003235